161 related articles for article (PubMed ID: 34093200)
1. Capsaicin and Proton Differently Modulate Activation Kinetics of Mouse Transient Receptor Potential Vanilloid-1 Channel Induced by Depolarization.
Takahashi K; Araki K; Miyamoto H; Shirakawa R; Yoshida T; Wakamori M
Front Pharmacol; 2021; 12():672157. PubMed ID: 34093200
[TBL] [Abstract][Full Text] [Related]
2. Activation of transient receptor potential vanilloid 1 (TRPV1) by resiniferatoxin.
Raisinghani M; Pabbidi RM; Premkumar LS
J Physiol; 2005 Sep; 567(Pt 3):771-86. PubMed ID: 16037081
[TBL] [Abstract][Full Text] [Related]
3. TRPA1 Channels Modify TRPV1-Mediated Current Responses in Dorsal Root Ganglion Neurons.
Masuoka T; Kudo M; Yamashita Y; Yoshida J; Imaizumi N; Muramatsu I; Nishio M; Ishibashi T
Front Physiol; 2017; 8():272. PubMed ID: 28515697
[TBL] [Abstract][Full Text] [Related]
4. The biophysical and molecular basis of TRPV1 proton gating.
Aneiros E; Cao L; Papakosta M; Stevens EB; Phillips S; Grimm C
EMBO J; 2011 Mar; 30(6):994-1002. PubMed ID: 21285946
[TBL] [Abstract][Full Text] [Related]
5. Single-channel properties of native and cloned rat vanilloid receptors.
Premkumar LS; Agarwal S; Steffen D
J Physiol; 2002 Nov; 545(1):107-17. PubMed ID: 12433953
[TBL] [Abstract][Full Text] [Related]
6. Presynaptic inhibition of transient receptor potential vanilloid type 1 (TRPV1) receptors by noradrenaline in nociceptive neurons.
Chakraborty S; Elvezio V; Kaczocha M; Rebecchi M; Puopolo M
J Physiol; 2017 Apr; 595(8):2639-2660. PubMed ID: 28094445
[TBL] [Abstract][Full Text] [Related]
7. Phenylarsine oxide as a redox modulator of transient receptor potential vanilloid type 1 channel function.
Carlin KP; Wu G; Patel A; Crumley G; Ilyin VI
J Neurosci Res; 2015 Feb; 93(2):309-20. PubMed ID: 25250537
[TBL] [Abstract][Full Text] [Related]
8. Camphor activates and strongly desensitizes the transient receptor potential vanilloid subtype 1 channel in a vanilloid-independent mechanism.
Xu H; Blair NT; Clapham DE
J Neurosci; 2005 Sep; 25(39):8924-37. PubMed ID: 16192383
[TBL] [Abstract][Full Text] [Related]
9. Background potassium channel block and TRPV1 activation contribute to proton depolarization of sensory neurons from humans with neuropathic pain.
Baumann TK; Chaudhary P; Martenson ME
Eur J Neurosci; 2004 Mar; 19(5):1343-51. PubMed ID: 15016092
[TBL] [Abstract][Full Text] [Related]
10. Pain-enhancing mechanism through interaction between TRPV1 and anoctamin 1 in sensory neurons.
Takayama Y; Uta D; Furue H; Tominaga M
Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5213-8. PubMed ID: 25848051
[TBL] [Abstract][Full Text] [Related]
11. Differential pH and capsaicin responses of Griffonia simplicifolia IB4 (IB4)-positive and IB4-negative small sensory neurons.
Liu M; Willmott NJ; Michael GJ; Priestley JV
Neuroscience; 2004; 127(3):659-72. PubMed ID: 15283965
[TBL] [Abstract][Full Text] [Related]
12. Agonist-dependent potentiation of vanilloid receptor transient receptor potential vanilloid type 1 function by stilbene derivatives.
Zhang X; Du XN; Zhang GH; Jia ZF; Chen XJ; Huang DY; Liu BY; Zhang HL
Mol Pharmacol; 2012 May; 81(5):689-700. PubMed ID: 22328719
[TBL] [Abstract][Full Text] [Related]
13. Protons stabilize the closed conformation of gain-of-function mutants of the TRPV1 channel.
Boukalova S; Teisinger J; Vlachova V
Biochim Biophys Acta; 2013 Mar; 1833(3):520-8. PubMed ID: 23220012
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Ca2+-dependent desensitization in the vanilloid receptor TRPV1 by calcineurin and cAMP-dependent protein kinase.
Mohapatra DP; Nau C
J Biol Chem; 2005 Apr; 280(14):13424-32. PubMed ID: 15691846
[TBL] [Abstract][Full Text] [Related]
15. Functional role of C-terminal cytoplasmic tail of rat vanilloid receptor 1.
Vlachová V; Teisinger J; Susánková K; Lyfenko A; Ettrich R; Vyklický L
J Neurosci; 2003 Feb; 23(4):1340-50. PubMed ID: 12598622
[TBL] [Abstract][Full Text] [Related]
16. Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia.
Amadesi S; Nie J; Vergnolle N; Cottrell GS; Grady EF; Trevisani M; Manni C; Geppetti P; McRoberts JA; Ennes H; Davis JB; Mayer EA; Bunnett NW
J Neurosci; 2004 May; 24(18):4300-12. PubMed ID: 15128844
[TBL] [Abstract][Full Text] [Related]
17. Block of native and cloned vanilloid receptor 1 (TRPV1) by aminoglycoside antibiotics.
Raisinghani M; Premkumar LS
Pain; 2005 Jan; 113(1-2):123-33. PubMed ID: 15621372
[TBL] [Abstract][Full Text] [Related]
18. Modulation of transient receptor vanilloid 1 activity by transient receptor potential ankyrin 1.
Spahn V; Stein C; Zöllner C
Mol Pharmacol; 2014 Feb; 85(2):335-44. PubMed ID: 24275229
[TBL] [Abstract][Full Text] [Related]
19. Chronic pain models amplify transient receptor potential vanilloid 1 (TRPV1) receptor responses in adult rat spinal dorsal horn.
Uta D; Yoshimura M; Koga K
Neuropharmacology; 2019 Dec; 160():107753. PubMed ID: 31493465
[TBL] [Abstract][Full Text] [Related]
20. A novel 3-(4,5-diphenyl-1,3-oxazol-2-yl)propanal oxime compound is a potent Transient Receptor Potential Ankyrin 1 and Vanilloid 1 (TRPA1 and V1) receptor antagonist.
Payrits M; Sághy É; Mátyus P; Czompa A; Ludmerczki R; Deme R; Sándor Z; Helyes Z; Szőke É
Neuroscience; 2016 Jun; 324():151-62. PubMed ID: 26930003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
